These innovative medications , Tirzepatide , represent a groundbreaking advancement in treating type 2 diabetes and possibly associated disorders. These drugs are classified as GLP-1 receptor activators , indicating these substances to mimic the body's GLP-1 substance , boosting insulin production and lowering hunger . Although Retatrutide each one